Tempest Therapeutics, Inc. (TPST) bonds
TPSTNasdaqPharmaceutical PreparationsFiscal year ends December 31
$0.38−0.00 (-0.29%)
Close on Nov 13, 2026Market cap $5.65MP/E –Yield –
Debt
Borrowings on the balance sheet, Sep 30, 2026
Tempest Therapeutics reports no long-term debt line
Its balance sheet in XBRL does not include long-term debt, so totals and interest cost cannot be shown.
Notes and loans outstanding
As tagged in Tempest Therapeutics's 10-Q for the period ended Jan 31, 2022
Tempest Therapeutics's filings do not break debt down by note
The debt footnote in the annual report has no machine-readable detail for individual notes, so coupons and maturities cannot be listed.
Credit facilities
Revolving credit lines and other committed borrowing capacity
| Facility | Size |
|---|---|
| Letter of Credit | $388.00K |
See a number that looks wrong?